Why Aren’t Digital Pills Taking Off?
In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. The enthusiasm for digital approaches involving sensors, apps, and wearables that could transmit information across systems, commonly grouped under the term Internet of Things, also spread. Yet, despite the landmark FDA approval, digital pills have not exploded in pharma. Privacy and logistical concerns, especially while studying such applications for vulnerable populations, have lingered.
Morphogenesis Gets Closer to a Cancer Vaccine
UF Startup and Sid Martin graduate company Morphogenesis, says it is getting closer to a shot that would treat some skin cancers.
Using AI, UF Startup Companies Boost Ailing Citrus Industry
As news broke that Florida’s citrus industry ended this year’s growing season with its lowest production in eight decades, an unlikely union has formed between two University of Florida startup companies to help reverse the trend.
Exactech Announces Successful First Surgeries With Latest Instrumentation for Its Newton™ Balanced Knee Technology
UF startup Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today first surgeries leveraging the power of the Newton™ Knee, featuring new, user-friendly instrumentation and a modernized graphical user interface. With a rich array of pre-clinical data, the Newton Knee is at the forefront of Exactech’s focus to improve clinical outcomes by utilizing soft tissue balancing technology in total knee replacement patients
Cannabix Technologies Participates in New Southern United States Study With Marijuana Breathalyzer Technology
UF startup Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace reports that the Company is participating in a new comprehensive multi-analysis study of subjects under the influence of marijuana. The new study will work along side toxicologists and law enforcement officers in the southern United States.
CEO of UF Startup AxoGen is appointed to EyePoint Pharmaceuticals Board of Directors
EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced the appointment of Karen Zaderej to its Board of Directors. Ms. Zaderej is currently the President, Chief Executive Officer and Chair of the Board at UF Startup and Accelerate graduate AxoGen, Inc., and brings more than 35 years of biopharmaceutical and medical device experience to the role.
DHS Prize Winners Announced in $195K Challenge To Counter Extreme Temperatures
The U.S. Department of Homeland Security (DHS) announced that UF startup and Accelerate resident Micro Nano Technologies, as one of their winners in the Cooling Solutions Challenge prize competition. The winners were each awarded funding, which totaled $195,000, for their innovative and creative ideas that sought climate-friendly cooling solutions to protect people in extreme heat conditions.
What Does a Dog’s Nose Know? A.I. May Soon Tell Us
UF Accelerate client Canaery, thinks it can read the neurons firing in a dog’s olfactory bulb in real-time and, with the help of machine learning, turn the animal into a detection device able to suss out a vast range of molecules, all without the animal having to be specially trained. “This does for scent what machine vision did for sight,” says Gabriel Lavella, Canaery’s founder and chief executive officer.
Leaders in Agriculture and Aerospace Partner To Create Rapid Crop Evaluation for Farmers
SATLANTIS LLC (SATLANTIS) and Agriculture Intelligence, Inc (AgIntel) announced a collaborative initiative with leading industry experts to combine agriculture intelligence and high resolution satellite monitoring with hopes to enhance current crop evaluation techniques for growers significantly. In late May, SATLANTIS successfully launched a satellite from the Cape Canaveral Force Station on board a SpaceX Falcon 9 rocket.
Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a biotech company dedicated to fighting infectious diseases including coronaviruses, announces the appointment of Ms. Kimberly M. Murphy, member of the Board of Directors, as President and Chief Executive Officer effective June 23, 2022. Ms. Murphy brings more than 25 years of vaccine industry experience at leading pharmaceutical companies including serving as a key leader in the successful US and Global launch of Merck’s HPV/Gardasil Franchise. Ms. Murphy joined Oragenics’ Board of Directors in 2020.
